Korro Bio Inc.
KRRO | NASDAQ
$9.98
-$0.04 (-0.40%)
At close: Sep 21, 2026, 4:00 PM ET
$10
+$0.02 (+0.20%)
Pre-market:
Sep 22, 2026, 8:24 AM ET
Market Data
Market Cap $99.33M
Enterprise Value $26.51M
Beta 2.25
Average Volume 161.89K
Shares Outstanding (Diluted) 17.62M
Shares Change YoY 87.62%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US5009461089
Price Performance
Price Change 1M -24.3%
Price Change 3M -27.2%
Price Change 6M -8.6%
Price Change YTD 24.0%
Price Change 1Y -70.8%
Price Change 3Y -47.6%
Price Change 5Y -97.3%
1M CAGR (ann.) -24.7%
1Y CAGR (ann.) -70.0%
5Y CAGR (ann.) -51.0%
All-Time CAGR -45.5%
Valuation
PE Ratio -1.00
Forward PE N/A
PEG Ratio 0.07
Forward PEG 0.12
PS Ratio 41.70
Forward PS 189.20
PB Ratio 0.96
P/FCF Ratio -1.18
P/Adj. FCF Ratio -1.05
P/OCF Ratio -2.59
EV/Sales 11.13
EV/EBIT -0.36
EV/EBITDA -0.38
EV/FCF -0.31
Earnings Yield -100.3%
FCF Yield -84.9%
Adj. FCF Yield -95.2%
Financial Health
Net Cash $72.82M
Total Debt $42.21M
Cash & Short-Term Investments $115.04M
Total Assets $163.45M
Current Ratio 9.55
Quick Ratio 9.55
Debt / Equity Ratio 0.41
Debt / EBITDA -0.60
Debt / FCF -0.50
OCF / Debt -1.99
Interest Coverage 0.00
Altman Z-Score -3.30
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 72.8%
Operating Profit Margin -3176.6%
EBITDA Margin -3019.2%
Net Profit Margin -4477.1%
FCF Margin -3541.6%
Adj. FCF Margin -3971.3%
SBC / Revenue 315.1%
SBC Impact (per share) -12.1%
Returns
Return on Assets -65.3%
Return on Equity -114.3%
Return on Invested Capital -49.2%
Return on Capital Employed -50.2%
Return on Tangible Assets -65.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 41.2%
Revenue CAGR 5Y -41.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 8.5%
EPS CAGR 5Y 70.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y 13.2%
FCF CAGR 5Y -6.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 18.3%
Revenue Growth Next 3Y 89.3%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$1.25
EPS Growth Est (next Q) -35.0%
Revenue Est (next Q) $187.5K
Revenue Growth Est (next Q) -82.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $15
Price Target Upside 50.3%
Cash Flow
Operating Cash Flow $-84.02M
Free Cash Flow $-84.36M
Adj. Free Cash Flow $-94.6M
FCF Per Share -$3.87
OCF Per Share -$3.86
OCF/S Ratio -2852.6%
Income Statement
Revenue $2.38M
Gross Profit $1.35M
Operating Income $-75.67M
EBITDA $-70.62M
Net Income $-106.64M
EPS (Diluted) -$10.01
Revenue / Employee $41.79K
Profit / Employee $-1.87M
Employees 57
Add to Watchlist
Select watchlists to add or remove KRRO